nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-sectional study on the relationship between cardiorespiratory fitness, disease severity and walking speed in persons with Multiple Sclerosis
|
Madsen, Laurits T. |
|
2019 |
29 |
C |
p. 35-40 |
artikel |
2 |
Acute flaccid myelitis in the 21st century: reminiscence of poliomyelitis or a new emergent disease
|
Levy, Michael |
|
2019 |
29 |
C |
p. A1-A2 |
artikel |
3 |
Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG35-55 peptide
|
Heidari, Amir Reza |
|
2019 |
29 |
C |
p. 68-82 |
artikel |
4 |
Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack
|
Yang, Xinguang |
|
2019 |
29 |
C |
p. 94-99 |
artikel |
5 |
Bilateral cingulate cortices lesions in two autoantibodies directed against MOG (MOG-Ab)-positive patients
|
Kamada, Takashi |
|
2019 |
29 |
C |
p. 108-110 |
artikel |
6 |
Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study
|
Pilutti, Lara A. |
|
2019 |
29 |
C |
p. 41-47 |
artikel |
7 |
Commentary on the manuscript "the neuromyelitis optica presentation in HIV seropositive patients"
|
Mathew, Thomas |
|
2019 |
29 |
C |
p. 156 |
artikel |
8 |
Core temperature is not elevated at rest in people with relapsing-remitting multiple sclerosis
|
Chaseling, Georgia K |
|
2019 |
29 |
C |
p. 62-67 |
artikel |
9 |
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
|
Comi, Giancarlo |
|
2019 |
29 |
C |
p. 168-174 |
artikel |
10 |
Effect of vitamin D replacement on depression in multiple sclerosis patients
|
Kotb, Mamdouh Ali |
|
2019 |
29 |
C |
p. 111-117 |
artikel |
11 |
Erythroblast appearance associated with natalizumab
|
Kobayashi, Yuya |
|
2019 |
29 |
C |
p. 145-147 |
artikel |
12 |
Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis
|
Grahl, S. |
|
2019 |
29 |
C |
p. 124-129 |
artikel |
13 |
Gait abnormalities in minimally disabled people with Multiple Sclerosis: A 3D-motion analysis study
|
Liparoti, Marianna |
|
2019 |
29 |
C |
p. 100-107 |
artikel |
14 |
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability
|
Kiselev, Ivan |
|
2019 |
29 |
C |
p. 130-136 |
artikel |
15 |
How much does balance and muscle strength impact walking in persons with multiple sclerosis? - A cross-sectional study
|
Callesen, Jacob |
|
2019 |
29 |
C |
p. 137-144 |
artikel |
16 |
Interferon alpha might be an alternative therapeutic choice for refractory Neuro-Behçet's disease
|
Bolek, Ertugrul Cagri |
|
2019 |
29 |
C |
p. 153 |
artikel |
17 |
Lyme myelopathy: Case report and literature review of a rare but treatable disorder
|
Kaiser, Eric A. |
|
2019 |
29 |
C |
p. 1-6 |
artikel |
18 |
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity?
|
Gobbin, Francesca |
|
2019 |
29 |
C |
p. 23-25 |
artikel |
19 |
Pachymeningitis with optic neuropathy associated with extrapulmonary tuberculosis and secondary antiphospholipid syndrome
|
De Stefano, Pia |
|
2019 |
29 |
C |
p. 83-85 |
artikel |
20 |
Pediatric glial fibrillary acidic protein meningoencephalomyelitis: A case report and review of the literature
|
Francisco, Carla |
|
2019 |
29 |
C |
p. 148-152 |
artikel |
21 |
Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease
|
Salama, Sara |
|
2019 |
29 |
C |
p. 15-22 |
artikel |
22 |
Response to correspondence: “Interferon alpha might be an alternative therapeutic choice for refractory neuro-Behçet's disease” – Authors reply
|
London, Frédéric |
|
2019 |
29 |
C |
p. 154 |
artikel |
23 |
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis
|
Cook, Stuart |
|
2019 |
29 |
C |
p. 157-167 |
artikel |
24 |
Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)
|
Vukusic, Sandra |
|
2019 |
29 |
C |
p. 7-14 |
artikel |
25 |
Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment
|
Pitteri, Marco |
|
2019 |
29 |
C |
p. 118-123 |
artikel |
26 |
Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis
|
McCool, Rachael |
|
2019 |
29 |
C |
p. 55-61 |
artikel |
27 |
Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRI
|
Eisele, Philipp |
|
2019 |
29 |
C |
p. 48-54 |
artikel |
28 |
The neuromyelitis optica presentation in HIV seropositive patients
|
Bhigjee, Ahmed I |
|
2019 |
29 |
C |
p. 155 |
artikel |
29 |
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes
|
Fitzgerald, Kathryn C. |
|
2019 |
29 |
C |
p. 86-93 |
artikel |
30 |
Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis
|
Soares, Jaine LS |
|
2019 |
29 |
C |
p. 26-34 |
artikel |